The Claim

Bimagrumab administration for six months does not elevate cardiac biomarkers of injury or stress, including troponin T, NT-proBNP, or creatine kinase, in healthy older adults.

Source: Cardiac Safety of Chronic Inhibition of the Myostatin-Activin Pathway with Bimagrumab in Healthy Older Adults.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
76score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Description
1 study reviewed
In plain English

Taking bimagrumab for six months does not increase levels of troponin T, NT-proBNP, or creatine kinase in healthy older adults.

See the scientific wording

Bimagrumab does not elevate cardiac biomarkers of injury or stress—including troponin T, NT-proBNP, or creatine kinase—in healthy older adults over six months of treatment.

Why this might work

Blocking a specific receptor in muscle and fat cells causes muscles to grow larger and fat to decrease, but the heart does not respond because the muscle gain is too small to demand more work from the heart, and the drug does not directly affect heart cells.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Cardiac Safety of Chronic Inhibition of the Myostatin-Activin Pathway with Bimagrumab in Healthy Older Adults.

    This study gave older adults bimagrumab for six months and checked their hearts with advanced scans. Their hearts stayed healthy and showed no signs of stress or damage, which means the drug likely doesn't harm the heart, even though they didn't measure the exact blood tests mentioned.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.